The tail of polycystin-1 pays the kidney a complement.

for those interested in the relationship between cellular signaling pathways and pathophysiology, autosomal dominant polycystic kidney disease (ADPKD) offers almost an embarrassment of riches. ADPKD is the most common potentially lethal genetic disease, affecting >1 in 1,000 individuals ([5][1]). It

[1]  Jie Zhou,et al.  The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1. , 2016, American journal of physiology. Renal physiology.

[2]  R. Zietse,et al.  Proteomics of Urinary Vesicles Links Plakins and Complement to Polycystic Kidney Disease. , 2016, Journal of the American Society of Nephrology : JASN.

[3]  C. Pan,et al.  Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease , 2014, Journal of internal medicine.

[4]  V. Torres,et al.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. , 2014, The Journal of clinical investigation.

[5]  T. Weimbs,et al.  Regulation of STATs by polycystin-1 and their role in polycystic kidney disease , 2013, JAK-STAT.

[6]  D. Wallace,et al.  Macrophages promote polycystic kidney disease progression , 2013, Kidney international.

[7]  X. Cui,et al.  Kidney injury accelerates cystogenesis via pathways modulated by heme oxygenase and complement. , 2012, Journal of the American Society of Nephrology : JASN.

[8]  J. Baggs,et al.  The γ-secretase cleavage product of polycystin-1 regulates TCF and CHOP-mediated transcriptional activation through a p300-dependent mechanism. , 2012, Developmental cell.

[9]  V. Takiar,et al.  Polycystic kidney disease: pathogenesis and potential therapies. , 2011, Biochimica et biophysica acta.

[10]  L. Cantley,et al.  Macrophages promote cyst growth in polycystic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[11]  J. Shillingford,et al.  Polycystin-1 regulates STAT activity by a dual mechanism , 2011, Proceedings of the National Academy of Sciences.

[12]  M. Caplan,et al.  The cell biology of polycystic kidney disease , 2010, The Journal of cell biology.

[13]  A. Boletta,et al.  Identification of a Polycystin-1 Cleavage Product, P100, That Regulates Store Operated Ca2+ Entry through Interactions with STIM1 , 2010, PloS one.

[14]  Bob van de Water,et al.  Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. , 2009, Human molecular genetics.

[15]  V. Torres,et al.  Polycystic kidney disease. , 2009, Annual review of medicine.

[16]  M. Caplan,et al.  Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. , 2008, Human molecular genetics.

[17]  R. Bacallao,et al.  Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients , 2008, Proteomics. Clinical applications.

[18]  T. Weimbs,et al.  Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. , 2006, Developmental cell.

[19]  J. García Rodríguez,et al.  [Polycystic Kidney Disease]. , 2005, Actas urologicas espanolas.

[20]  O. Ibraghimov-Beskrovnaya,et al.  Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. , 2004, The Journal of clinical investigation.

[21]  G. Germino,et al.  Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations , 2002, Proceedings of the National Academy of Sciences of the United States of America.